Identification Of Biomarkers To Monitor The Activity Of STX-100, A Humanized Anti-±v²6 Antibody, In A Phase 2a Trial In Idiopathic Pulmonary Fibrosis
Violette S, Sheppard D, Rosas I, Arjomandi M, Rice T, Gilman M, Kaminski N, Prasse A, Maroni B. Identification Of Biomarkers To Monitor The Activity Of STX-100, A Humanized Anti-±v²6 Antibody, In A Phase 2a Trial In Idiopathic Pulmonary Fibrosis. 2012, a2659-a2659. DOI: 10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2659.Peer-Reviewed Original ResearchPhase 2a trialIdiopathic pulmonary fibrosisIdentification of biomarkersPulmonary fibrosisFibrosisTrialsBiomarkersAntibodies